Table 2.
IFNγ | IL–10 | IL–12p40 | IL–12p70 | CRP | ||||||
---|---|---|---|---|---|---|---|---|---|---|
(pg/ml) | P-value | (pg/ml) | P-value | (pg/ml) | P-value | (pg/ml) | P-value | (mg/l) | P-value | |
Control | 20‡ (10–117) | 20 (9–126) | 298 (117–581) | 0·9 (0·1–2·4) | 2 (0·1–60) | |||||
Uncomplicatedmalaria | ND | 39 (20–3190) | 0·001* | 275 (150–2672) | 0·6* | ND | 63 (14–522) | <0·001* | ||
Severe malaria | 10 (1–1132) | 0·04* | 2496 (18–21020) | <0·001* | 242 (55–2456) | 0·9* | 1·5 (0·1–11·4) | 0·05* | 217 (15–545) | <0·001* |
<0·001§ | 0·4§ | <0·001§ |
median concentrations on day of enrolment (range).
P-value as compared to control value.
P-value as compared to uncomplicated malaria. ND, Not Done.